Mylène Tajan

1.6k total citations
12 papers, 816 citations indexed

About

Mylène Tajan is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Mylène Tajan has authored 12 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Mylène Tajan's work include Protein Tyrosine Phosphatases (6 papers), Galectins and Cancer Biology (6 papers) and RNA modifications and cancer (3 papers). Mylène Tajan is often cited by papers focused on Protein Tyrosine Phosphatases (6 papers), Galectins and Cancer Biology (6 papers) and RNA modifications and cancer (3 papers). Mylène Tajan collaborates with scholars based in France, United Kingdom and United States. Mylène Tajan's co-authors include Karen H. Vousden, Thomas Édouard, Armelle Yart, Philippe Valet, Christiaan F. Labuschagne, Andreas Hock, Neil Robertson, Peter D. Adams, Flore Kruiswijk and Julianna Blagih and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Mylène Tajan

12 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mylène Tajan France 8 624 266 221 161 74 12 816
Stephan Geley Austria 14 634 1.0× 168 0.6× 119 0.5× 185 1.1× 40 0.5× 16 879
Qi Che China 22 578 0.9× 117 0.4× 395 1.8× 188 1.2× 46 0.6× 30 948
Junichi Furuta Japan 16 503 0.8× 97 0.4× 137 0.6× 144 0.9× 57 0.8× 43 909
Laura Antonucci Italy 14 446 0.7× 101 0.4× 120 0.5× 209 1.3× 28 0.4× 21 746
Yanxia Ning China 16 272 0.4× 151 0.6× 116 0.5× 151 0.9× 39 0.5× 24 605
Michael Batie United Kingdom 14 522 0.8× 108 0.4× 421 1.9× 74 0.5× 68 0.9× 20 792
Takamasa Kanbe Japan 11 484 0.8× 118 0.4× 121 0.5× 114 0.7× 146 2.0× 17 845
Jee‐Youn Kim South Korea 13 472 0.8× 76 0.3× 236 1.1× 130 0.8× 49 0.7× 28 696
Alden C. Klarer United States 10 516 0.8× 114 0.4× 418 1.9× 130 0.8× 42 0.6× 12 731
Joy M. Calaoagan United States 13 730 1.2× 60 0.2× 384 1.7× 164 1.0× 69 0.9× 18 947

Countries citing papers authored by Mylène Tajan

Since Specialization
Citations

This map shows the geographic impact of Mylène Tajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mylène Tajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mylène Tajan more than expected).

Fields of papers citing papers by Mylène Tajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mylène Tajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mylène Tajan. The network helps show where Mylène Tajan may publish in the future.

Co-authorship network of co-authors of Mylène Tajan

This figure shows the co-authorship network connecting the top 25 collaborators of Mylène Tajan. A scholar is included among the top collaborators of Mylène Tajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mylène Tajan. Mylène Tajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
D’Avola, Annalisa, Nathalie Legrave, Mylène Tajan, et al.. (2024). PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. Journal of Clinical Investigation. 134(4). 1 indexed citations
2.
Tajan, Mylène, Isabelle Castan‐Laurell, Philippe Valet, et al.. (2022). The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?. Biomedicines. 10(9). 2139–2139. 3 indexed citations
3.
D’Avola, Annalisa, Nathalie Legrave, Mylène Tajan, et al.. (2022). PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.. Figshare. 25 indexed citations
4.
Hennequart, Marc, Christiaan F. Labuschagne, Mylène Tajan, et al.. (2021). The impact of physiological metabolite levels on serine uptake, synthesis and utilization in cancer cells. Nature Communications. 12(1). 6176–6176. 32 indexed citations
5.
Tajan, Mylène & Karen H. Vousden. (2020). Dietary Approaches to Cancer Therapy. Cancer Cell. 37(6). 767–785. 132 indexed citations
6.
Tajan, Mylène, Andreas Hock, Julianna Blagih, et al.. (2018). SPOT-010 A role for P53 in the adaptation to glutamine starvation through the expression of Slc1a3. ESMO Open. 3. A19–A20. 2 indexed citations
7.
Tajan, Mylène, Andreas Hock, Julianna Blagih, et al.. (2018). A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3. Cell Metabolism. 28(5). 721–736.e6. 173 indexed citations
8.
Tajan, Mylène, et al.. (2018). The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway. Endocrine Reviews. 39(5). 676–700. 155 indexed citations
9.
Tajan, Mylène, Isabelle Gennero, Florence Capilla, et al.. (2018). Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth. Human Molecular Genetics. 27(13). 2276–2289. 33 indexed citations
10.
Tajan, Mylène, et al.. (2015). SHP2 sails from physiology to pathology. European Journal of Medical Genetics. 58(10). 509–525. 171 indexed citations
11.
Édouard, Thomas, Mylène Tajan, Toshiyuki Araki, et al.. (2012). Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature. Proceedings of the National Academy of Sciences. 109(11). 4257–4262. 88 indexed citations
12.
Édouard, Thomas, Karine Tréguer, Mylène Tajan, et al.. (2012). Noonan syndrome causing-SHP2 mutants inhibit IGF-I release via GH-induced ERK1/2 hyper-activation, which contributes to short stature. Annales d Endocrinologie. 73(4). 251–252. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephan Geley Breakdown of academic impact, for papers by Qi Che Breakdown of academic impact, for papers by Junichi Furuta Breakdown of academic impact, for papers by Laura Antonucci Breakdown of academic impact, for papers by Yanxia Ning Breakdown of academic impact, for papers by Michael Batie Breakdown of academic impact, for papers by Takamasa Kanbe Breakdown of academic impact, for papers by Jee‐Youn Kim Breakdown of academic impact, for papers by Alden C. Klarer Breakdown of academic impact, for papers by Joy M. Calaoagan
Rankless by CCL
2026